Skip to Main Content

Paper Details

IDH1 p.R132H ctDNA and D-2-hydroxyglutarate as CSF biomarkers in patients with IDH-mutant gliomas.
J Neurooncol
8
2022
Author NameAffiliation
Roy RiascosMcGovern Medical School, The University of Texas Health Science Center at Houston
Roy RiascosMemorial Hermann Hospital-TMC
Yoshua EsquenaziVivian L. Smith Department of Neurosurgery McGovern Medical School, The University of Texas Health Science Center
Yoshua EsquenaziMemorial Hermann Hospital-TMC
Yoshua EsquenaziCenter for Precision Health, McGovern Medical School, The University of Texas Health Science Center at Houston
  • 1 - 5

Datasets